NEUARTIGE KALIUMKANALINHIBITOREN
European patent · EP4313973 · In force
Register entry
- Publication number
- EP4313973
- Application number
- EP22716200
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 17, 2022
- Published
- Feb 7, 2024
- Granted
- Oct 14, 2026
- Protection ends at the latest
- Mar 16, 2042
- Next annual fee due
- Mar 31, 2027
- IPC classes
- C07D 403/12 (2006.01)C07D 413/06 (2006.01)C07D 413/12 (2006.01)A61P 9/00 (2006.01)A61K 31/422 (2006.01)
- Priority
- EP 21164078 22.03.2021
- PCT application
- PCT/EP2022/056955 17.03.2022
- PCT publication
- WO2022/200162 29.09.2022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 14, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 14.10.2026
Parties
Inventor
METE, Antonio
2000 Frederiksberg, GB
SØRENSEN, Ulrik
2000 Frederiksberg, DK
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.